Canaan Partners is an early-stage venture capital firm founded in 1987 and based in San Francisco, California, with additional offices in Westport, Connecticut, Israel, and India. The firm specializes in investing in entrepreneurs with innovative ideas across various sectors, primarily focusing on technology and healthcare. Canaan manages over $5 billion in capital and has invested in more than 250 companies, achieving over 190 exits. Its investment strategy encompasses a range of sectors, including fintech, enterprise/cloud, digital health, biopharma, medical technology, and frontier tech, with funding capabilities from $1 million to $20 million. The firm is recognized for its experienced team of investment professionals who leverage their extensive backgrounds in technology, infrastructure, communications, and life sciences to support promising ventures at various stages of development.
Cynomi offers an AI-powered, automated virtual Chief Information Security Officer (vCISO) platform designed to assist Managed Security Service Providers (MSSPs) and consulting firms in delivering vCISO services efficiently and at scale. Founded in 2021 and based in London, the company’s multi-tenant platform automatically generates essential components for vCISO services, including risk and compliance assessments, customized security policies, and actionable remediation plans with prioritized tasks. Additionally, it provides task management tools and customer-facing reports, ensuring that organizations can maintain optimal cybersecurity posture and regulatory compliance. Cynomi's solution enables businesses to enhance their security measures without the need to expand existing resources.
AttoTude
Series B in 2025
AttoTude is a pioneer in the creation of novel connection technology for AI and hyperscale data center applications. The company is developing a distinctive technology for high-speed data networking that will overcome the constraints of current interconnect systems, including considerable increases in bandwidth, power dissipation, reliability, and cost.
Page
Seed Round in 2025
Page, an AI-powered external relations platform that provides real-time insights to help enterprises navigate government policies, media, and regulations.
Vivace Therapeutics
Series D in 2025
Vivace Therapeutics, Inc. is a drug discovery and development company focused on creating cancer therapies that target the Hippo pathway, which plays a crucial role in tissue regeneration and organ development. Established in 2014 and located in the San Francisco Bay Area, Vivace Therapeutics employs an innovative approach to develop small molecule treatments aimed at improving patient outcomes in oncology. The company collaborates with leading academic institutions to advance research and develop therapies that can be used alone or in combination with existing treatments. With a commitment to enhancing cancer care, Vivace Therapeutics is dedicated to delivering novel solutions that can help patients combat cancer more effectively.
HeyMilo
Seed Round in 2025
Deploy interoperable generative AI agents for various end-user interactions.
Wise Layer
Seed Round in 2025
WiseLayer makes AI-powered digital workers for finance and accounting teams. It's AI digital workforce includes: - Angela, the AI agent for Accruals & Rev Rec (hire her at www.accruals.ai) - Dennis, the AI agent for Discrepancies & Financial Anomalies (hire him at www.discrepancies.ai) - … with the 4 newest AI agents eachspecializing in the following tasks: (1) bank reconciliations, (2) fixed asset depreciation & amortization, (3) lease accounting, and (4) prepaid expenses.
Enterpret
Series A in 2024
Enterpret is a company that specializes in customer feedback analytics, offering a platform that centralizes and analyzes customer input from various channels. The platform enables businesses to collect and transform unstructured feedback into actionable intelligence, thus enhancing product development and customer insights. By leveraging advanced technologies such as natural language processing, Enterpret helps organizations identify emerging trends and anomalies in customer feedback. Additionally, the platform integrates seamlessly with product analytics, allowing clients to gain deeper insights into customer needs and preferences, ultimately driving growth and improving overall customer experience.
Nivoda
Series C in 2024
Nivoda Limited is a business-to-business online marketplace based in London, with an additional office in Hong Kong, that specializes in the buying and selling of diamonds and jewelry. Founded in 2017, Nivoda simplifies the global jewelry trade by providing a platform that connects jewelry businesses with verified suppliers, allowing them to browse a wide selection of diamonds and gemstones. The marketplace enables users to purchase goods efficiently from anywhere in the world through a single checkout process, helping clients source diamonds at competitive prices while minimizing logistical hurdles and additional costs associated with international purchases. Nivoda's aim is to enhance profits and accelerate growth for jewelry businesses by streamlining the sourcing process.
Glooko
Series F in 2024
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
AttoTude
Series A in 2024
AttoTude is a pioneer in the creation of novel connection technology for AI and hyperscale data center applications. The company is developing a distinctive technology for high-speed data networking that will overcome the constraints of current interconnect systems, including considerable increases in bandwidth, power dissipation, reliability, and cost.
Halda Therapeutics
Series B in 2024
Halda Therapeutics is a research-stage drug discovery company focused on developing next-generation precision medicines. The company utilizes a novel therapeutic modality aimed at creating treatments that can address various disease states. By modifying disease-causing pathways, Halda Therapeutics seeks to enable healthcare providers to offer tailored therapies to patients, enhancing the effectiveness of treatment based on individual patient needs.
Autobahn Therapeutics
Series C in 2024
Autobahn Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing small molecule therapies for central nervous system (CNS) disorders. Since its incorporation in 2017, Autobahn has aimed to address significant unmet needs in neuropsychiatry and neuroimmunology through its innovative brain-targeting chemistry platform. The company's leading candidate, ABX-002, is a thyroid hormone receptor beta agonist being investigated as a potential treatment for multiple sclerosis and adrenomyeloneuropathy, as well as an adjunctive therapy for major depressive disorder and bipolar disorder depression. Autobahn Therapeutics emphasizes precision tuning of CNS exposure, targeting validated clinical and biological markers to enhance therapeutic opportunities and patient outcomes.
Greywolf Therapeutics
Series B in 2024
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly. We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. This approach marks a fundamental shift in how we treat people living with autoimmune disorders, cancers and infectious diseases.
Truveris
Series E in 2024
Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges. Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital.
Nivoda
Series B in 2024
Nivoda Limited is a business-to-business online marketplace based in London, with an additional office in Hong Kong, that specializes in the buying and selling of diamonds and jewelry. Founded in 2017, Nivoda simplifies the global jewelry trade by providing a platform that connects jewelry businesses with verified suppliers, allowing them to browse a wide selection of diamonds and gemstones. The marketplace enables users to purchase goods efficiently from anywhere in the world through a single checkout process, helping clients source diamonds at competitive prices while minimizing logistical hurdles and additional costs associated with international purchases. Nivoda's aim is to enhance profits and accelerate growth for jewelry businesses by streamlining the sourcing process.
Quantum Circuits
Venture Round in 2024
Quantum Circuits, Inc. specializes in the development and manufacture of quantum computers utilizing superconducting devices. Founded in 2015 and located in New Haven, Connecticut, the company aims to innovate in the field of quantum computing by delivering full-stack systems that efficiently scale. Led by Dr. Robert Schoelkopf, a prominent figure in quantum science, Quantum Circuits employs a unique dual-rail quantum qubit design that incorporates built-in hardware error detection and conversion. This approach allows for a highly scalable error-corrected system, requiring significantly fewer physical qubits per logical qubit and providing a more efficient pathway to fault-tolerant quantum computing. By focusing on solid-state quantum bits, the company enables clients to perform error-free computations, thereby accelerating research and advancing the practical applications of quantum technology.
Qlaris Bio
Series B in 2024
Qlaris Bio, Inc. is a clinical-stage biotechnology company based in Wellesley, Massachusetts, focused on developing innovative therapies for serious ophthalmic diseases. Founded in 2017, the company is working on QLS-101, a therapy aimed at reducing intraocular pressure, a critical factor in conditions such as glaucoma. Qlaris Bio explores novel mechanisms to address episcleral venous pressure, which significantly contributes to intraocular pressure, thereby aiming to mitigate the risk of blindness associated with both Primary Open Angle Glaucoma and Normal Tension Glaucoma. The company also targets high unmet medical needs in pediatric rare diseases related to intraocular pressure disturbances, where effective treatment options are currently limited.
Cynomi
Series A in 2024
Cynomi offers an AI-powered, automated virtual Chief Information Security Officer (vCISO) platform designed to assist Managed Security Service Providers (MSSPs) and consulting firms in delivering vCISO services efficiently and at scale. Founded in 2021 and based in London, the company’s multi-tenant platform automatically generates essential components for vCISO services, including risk and compliance assessments, customized security policies, and actionable remediation plans with prioritized tasks. Additionally, it provides task management tools and customer-facing reports, ensuring that organizations can maintain optimal cybersecurity posture and regulatory compliance. Cynomi's solution enables businesses to enhance their security measures without the need to expand existing resources.
Alterome Therapeutics
Series B in 2024
Alterome Therapeutics is a biotechnology company focused on precision oncology, dedicated to developing targeted therapeutics that specifically address validated oncogenic drivers in cancer. The firm aims to discover and create alteration-specific therapies that provide hope and improved treatment options for individuals affected by cancer. By concentrating on high-value oncogenic alterations, Alterome Therapeutics seeks to enhance the effectiveness of cancer treatments and support healthcare providers in their efforts to combat the disease.
Binarly
Seed Round in 2024
Binarly is a firmware and software supply chain security company established in 2021, headquartered in Los Angeles, California. The company's primary offering, the Binarly Transparency Platform, is an AI-powered solution designed for device manufacturers, OEMs, and product security teams. This platform identifies known and unknown vulnerabilities, misconfigurations, and potential malicious code within firmware, employing advanced machine learning and code analysis techniques. By providing validated remediation playbooks, Binarly helps organizations significantly reduce the time and cost associated with addressing security exposures. The company leverages decades of research and expertise in program analysis to develop solutions that safeguard businesses, critical infrastructure, and consumers from emerging firmware and hardware threats.
Lily AI
Series B in 2024
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Nocion Therapeutics
Series B in 2024
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.
HeyMilo
Seed Round in 2024
Deploy interoperable generative AI agents for various end-user interactions.
Anzenna
Seed Round in 2024
68% of security breaches are due to insiders. Anzenna is an Agentless platform that stops Insider Risk in minutes.
JOOR
Venture Round in 2023
JOOR, Inc. operates an online global fashion marketplace that facilitates wholesale buying by connecting brands and retailers. Founded in 2010 and headquartered in New York, the company also has offices in Los Angeles, London, Milan, Paris, Sydney, and Melbourne. JOOR aims to enhance the wholesale purchasing process by digitizing and streamlining operations, thereby eliminating manual tasks that are often time-consuming and prone to errors. This digital platform not only allows brands and retailers to increase revenue and reduce costs but also enhances customer experience and enables performance monitoring through data analytics. Additionally, JOOR has established a strategic partnership with ORDRE to further its mission in the fashion industry.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.
Acesion Pharma
Series B in 2023
Acesion Pharma ApS is a biotech company based in Copenhagen, Denmark, founded in 2011. The company specializes in the development of medical drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. Acesion Pharma focuses on creating SK channel inhibitors, which target specific ion channels in heart cells that are essential for generating the electrical signals that regulate heart rhythm. By inhibiting these channels, the company aims to provide safe and tolerable chronic treatments that prevent the recurrence of AF and support the maintenance of a normal heart rhythm.
Diligent Robotics
Venture Round in 2023
Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.
Actio Biosciences
Series A in 2023
Actio Biosciences focuses on the development of precision medicines tailored for homogeneous rare patient populations. The company is engaged in creating a pipeline of innovative drugs aimed at treating rare diseases, with the potential to extend their application to more common illnesses. By utilizing biotechnology to modulate the activity of proteins linked to rare diseases, Actio Biosciences aims to enhance the likelihood of clinical success and deliver effective treatments for conditions that are often difficult to cure. Their commitment to addressing both rare and common diseases positions them to make a significant impact in the field of medicine.
Atmosfy
Seed Round in 2023
Atmosfy is a platform founded in 2021 and based in San Francisco, California, that specializes in discovering dining and nightlife options through video content. The platform allows users to explore various establishments, such as restaurants, bars, nightclubs, and cafes, both locally and from afar. Atmosfy enhances the decision-making process for users by providing video-based insights along with reviews and recommendations for each venue. This approach enables individuals to make informed choices about where to dine or socialize based on their personal preferences.
Savvy
Series A in 2023
Savvy is a software development company that engages in cybersecurity.
Tomorrow.io
Series E in 2023
Tomorrow.io operates a weather intelligence platform that delivers real-time, location-specific forecasts tailored to various industries affected by weather conditions. Utilizing advanced technologies such as wireless signals, connected vehicles, satellite communications, and traditional meteorological data, the platform provides accurate and customizable weather information. This enables clients, including notable organizations like the NFL, Uber, and Delta, to enhance operational efficiency, streamline communication, and optimize decision-making processes in response to weather challenges. Tomorrow.io's services are designed to improve productivity and profit margins across diverse sectors, with a presence in North America, Latin America, Europe, and Asia.
Trebol
Seed Round in 2023
We provide the technology infrastructure needed by business' neobanks and fintech lenders to underwrite fast and efficient financial services to their clients.
OncoResponse
Venture Round in 2023
OncoResponse Inc. is a Houston-based immuno-oncology company focused on discovering innovative cancer therapies through its proprietary human antibody platform. The company specializes in identifying fully human monoclonal antibodies that target high-value immuno-oncology targets, particularly those associated with immunosuppressive myeloid biology. By exploring the adaptive immune responses of cancer patients who have successfully undergone checkpoint inhibition, OncoResponse aims to develop therapeutic antibodies that can mitigate tumor microenvironment immunosuppression and enhance immune activation. This approach seeks to transform cold tumors into hot tumors, thereby improving treatment outcomes for cancer patients.
Antiva Biosciences
Series E in 2023
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.
Aer Therapeutics
Series A in 2023
Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.
Kepler
Series C in 2023
Kepler Communications Inc. specializes in satellite communications by designing, developing, and operating satellite infrastructure for space-based connectivity. The company focuses on creating a network of Low-Earth Orbit satellites that facilitate communication for various applications, including connecting space stations and devices. Its offerings include PolarConnect, which allows organizations in extreme environments to maintain global connectivity, and the Global Data Service, a high-bandwidth solution for transferring large data files from remote locations to the internet. Kepler is also developing everywhereIOT, a solution aimed at providing reliable, low-power connectivity for Internet of Things devices worldwide. Established in 2015 and headquartered in Toronto, Canada, Kepler serves diverse industries such as maritime, natural resources, research, defense, and logistics, positioning itself as a leader in addressing connectivity challenges in both terrestrial and space environments.
Assis
Seed Round in 2023
Assis goal is to empower business owners by helping them grow their companies through technology that gives customers an amazing experience each and every time they connect with them.
Mantra Health
Series A in 2023
Mantra Health is a digital mental healthcare company focused on providing mental health services specifically for university students. The company has developed a platform that includes a proprietary Collaboration Portal, allowing universities to create tailored telemental health programs that enhance clinical outcomes and decrease the time students wait to access care. Mantra Health's platform offers a range of services, including psychiatric care, online assessments, initial video consultations, and personalized care plans, all designed to facilitate easy and comfortable treatment for students in their own homes. This approach aims to improve the overall mental health of students across various educational institutions.
Relievant Medsystems
Venture Round in 2023
Relievant Medsystems, Inc. is a medical device company focused on developing minimally invasive treatments for chronic axial low back pain. The company has created the Intracept procedure, which specifically targets the basivertebral nerve to alleviate chronic vertebrogenic low back pain. By delivering targeted energy into the spine, the Intracept System effectively blocks the transmission of pain signals, providing patients with a low-risk therapeutic option. Founded in 2004, Relievant is headquartered in Minneapolis, Minnesota, with additional operations in Sunnyvale, California.
Greywolf Therapeutics
Series B in 2023
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly. We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. This approach marks a fundamental shift in how we treat people living with autoimmune disorders, cancers and infectious diseases.
Komprise
Series D in 2023
Komprise, Inc. is a data management company that specializes in intelligent software designed to store, organize, and analyze both on-premise and cloud-based data. Founded in 2014 and headquartered in Campbell, California, Komprise offers a multi-cloud data management-as-a-service platform that enables users to analyze and mobilize file and object data across various cloud environments. The company’s solution focuses on optimizing data storage by moving unstructured data to secondary storage based on factors such as age, usage, and security criteria. This approach allows organizations to effectively manage their data lifecycle through analytics, replication, archiving, and migration, ensuring that data remains accessible and appropriately situated. Komprise has established a strategic partnership with Ochser Consulting Group to enhance its service offerings.
WiseLayer
Seed Round in 2023
WiseLayer specializes in creating AI-powered digital workers tailored for finance and accounting teams. The company offers a suite of AI agents, each designed to streamline specific financial tasks. These include Angela, who manages accruals and revenue recognition, and Dennis, who addresses discrepancies and financial anomalies. In addition, WiseLayer provides four other AI agents focused on bank reconciliations, fixed asset depreciation and amortization, lease accounting, and prepaid expenses. Furthermore, WiseLayer has developed an early warning system that leverages artificial intelligence and analytics to help companies identify and mitigate potential financial issues. This system features pre-built tools that provide notifications and alerts, enabling clients to resolve problems quickly and efficiently while reducing stress associated with financial management.
Paway
Pre Seed Round in 2022
Paway, founded by Jason Meltzer, aims to enhance the pet care community for Gen-Z and Millennial pet owners. The company develops a pet tracking application that provides real-time safety alerts and neighborhood tips, promoting safer walks for pets and their owners. Users can create pet profiles and share experiences with caregivers, family, and friends, enabling effective communication and collaboration in pet care. Additionally, Paway supports pet care professionals by offering software tools to manage and grow their businesses, thereby fostering connections between these professionals and pet owners. By addressing consumer demand for improved pet care services, Paway seeks to lower costs, increase loyalty among pet professionals, and collect valuable user data, including pet details and location.
Normunity
Series A in 2022
Normunity is a biotechnology company focused on developing precision immuno-oncology medicines, specifically a new class known as immune normalizers. These medicines aim to target novel mechanisms that enhance the body’s natural immune response against cancer. In collaboration with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is researching newly-discovered mechanisms of immune disruption in cancer, utilizing proprietary discovery platforms to explore the intricate interactions between cancer and the immune system. The company is advancing a pipeline of immune normalizers, which includes initial drug programs designed to address the exclusion of T-cells from immune-sensitive tumors and other factors that impede normal immune function in cancer. Normunity operates from locations in Boston, Massachusetts, and West Haven, Connecticut.
Alkymi
Series A in 2022
Alkymi, Inc. is a New York-based company that specializes in developing a data inbox designed to manage unstructured data for enterprises. Founded in 2017, Alkymi provides an end-to-end solution that ingests and normalizes various forms of unstructured data, including documents, emails, PDFs, images, and XML. By leveraging advanced machine learning and automation, the platform empowers users in sectors such as financial services, compliance, human resources, and customer relationship management to convert raw data into actionable insights. This capability enhances decision-making processes, allowing organizations to respond swiftly to market changes and improve operational efficiency. Notable clients include leading firms in the private markets sector, which utilize Alkymi's technology to better scale investments and enhance client service.
Pin
Seed Round in 2022
Pin is a company that specializes in facilitating fundraising for organizations by connecting entrepreneurs with investors through a community fund platform. It offers comprehensive support services, including back office operations and legal and tax assistance, to help clubs establish and operate their investing vehicles. This enables both accredited and unaccredited investors to participate in funding opportunities, allowing entrepreneurs and community leaders to raise capital, network with potential investors, and effectively manage their investment portfolios.
EMTECH
Seed Round in 2022
EMTECH is a fintech company focused on modernizing central banks to enhance financial inclusion and market resilience. Founded in 2019 and headquartered in New York, EMTECH provides a cloud-based platform that facilitates the integration of regulatory compliance and central bank digital currencies. Their offerings include digital regulatory sandboxes for collaborative workflows, digital cash solutions, and tools for cross-border currency integration. By developing scalable and resilient digital infrastructure, EMTECH aims to support central banks in improving their operations and adapting to the demands of the Web3 era.
Aceiss
Seed Round in 2022
Aceiss is a developer of a compliance monitoring platform that enhances access security by providing visibility and insights into user access. The company's technology seamlessly integrates with existing applications and security infrastructure, allowing organizations to identify anomalous behavior and monitor privileged accounts. This capability enables businesses to anticipate potential security threats and take proactive measures to protect their sensitive information. By delivering immediate insights upon integration, Aceiss helps organizations strengthen their security posture and ensure compliance with regulatory requirements.
Contentsquare
Series F in 2022
Contentsquare is an AI-powered platform that provides rich and contextual insight through customer behaviors, feelings, and intent. The platform helps brands to transform their businesses digitally using digital experience analytics that allows them to take action through enterprise scale and build customer trust with security, privacy, and accessibility.
Hank
Seed Round in 2022
Hank is a digital platform dedicated to connecting adults aged 55 and older with others in their communities. It facilitates online interactions that lead to offline activities and friendships through a variety of curated group events, such as pickleball, canasta, and skydiving. The platform allows members to discover Hank-sponsored events in their area or create their own gatherings, fostering connections among individuals who share similar interests and passions. By focusing on active older adults, Hank aims to enhance social engagement and provide opportunities for learning and personal growth within a supportive community.
WorkMotion
Series B in 2022
WorkMotion is a global HR platform headquartered in Berlin, Germany, that facilitates the hiring and onboarding of international employees. Founded in 2020, the company offers a cloud-based workforce management platform that allows employers to recruit and manage employees worldwide without the need to establish legal entities in foreign countries. WorkMotion streamlines the hiring processes, consolidates global payroll accounting, and supports the management of freelancers, enabling organizations to efficiently hire and pay remote employees from around the globe.
Appsmith
Series B in 2022
Appsmith is a developer of an open-source low-code application platform established in mid-2019. The platform enables developers to efficiently build, deploy, and manage custom internal applications, particularly focusing on CRUD functionalities. With over 5 million downloads and usage among more than 1,000 enterprises across over 100 countries, Appsmith aims to simplify the development of internal tools by streamlining operations, automating processes, and facilitating the integration of various applications and data. Additionally, the platform enhances legacy applications by allowing developers to incorporate new features, all while maintaining enterprise-grade security and governance.
Lily AI
Venture Round in 2022
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Marvin.
Series A in 2022
Marvin is a B2B fintech company that specializes in transforming credit risk management for industries selling to retail. By utilizing credit card receivables as collateral for trade credit, Marvin offers a modern alternative to traditional Trade Credit Insurance. This innovative approach simplifies the financing process, enhances flexibility, and mitigates credit risk for both retailers and suppliers. By reducing friction in financial transactions, Marvin enables clients to increase sales and improve the overall shopping experience, ultimately allowing businesses to unlock credit and sell more effectively.
Dusty Robotics
Series B in 2022
Dusty Robotics, Inc. specializes in providing automated layout services for the construction industry through its innovative robot-powered tools. Founded in 2018 and based in Mountain View, California, the company offers the FieldPrinter, which translates digital building information modeling (BIM) designs into accurate, constructible layouts directly on construction-site floors. By synchronizing BIM information with on-site requirements, Dusty Robotics eliminates manual steps in the workflow, enhancing efficiency and reducing waste in labor and materials. The company serves a diverse range of clients, including owners, general contractors, subcontractors, and builders, aiming to streamline the design-build-operate lifecycle in construction projects.
Lev
Series B in 2022
Lev Inc is a New York-based company founded in 2019 that specializes in financial services, particularly in lending and capital management solutions for commercial real estate transactions. The company has developed a technology platform designed to digitize these transactions, utilizing machine learning and artificial intelligence to analyze historical data and lender activity. This innovative approach allows Lev to identify optimal financing scenarios and connect clients with appropriate lenders. Additionally, the platform facilitates communication and negotiation on behalf of clients, streamlining the process of securing financing for property transactions.
RenoFi
Series A in 2022
RenoFi operates a renovation financing marketplace that connects homeowners with local banks to facilitate home improvement loans. By utilizing a unique approach, RenoFi allows homeowners to borrow against the after renovation value of their properties rather than their current market value, which helps them access larger loan amounts at lower interest rates. The company partners with various lenders who use its technology platform to offer these specialized renovation loans and related home valuation services. This innovative model enables homeowners to secure instant financing for renovations, ultimately increasing the mortgage value of their homes.
Hermeus
Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.
Rondo Therapeutics
Series A in 2022
Rondo Therapeutics is a biotechnology company focused on the discovery and development of novel bispecific antibodies aimed at activating the immune system to combat cancer. Founded in 2021 and based in Hayward, California, the company specializes in creating cancer immunotherapies specifically for solid tumor types that do not respond to conventional immune checkpoint inhibitors. By targeting areas of unmet medical need, Rondo Therapeutics enables researchers to advance innovative drug solutions in the fight against cancer.
EMTECH
Seed Round in 2022
EMTECH is a fintech company focused on modernizing central banks to enhance financial inclusion and market resilience. Founded in 2019 and headquartered in New York, EMTECH provides a cloud-based platform that facilitates the integration of regulatory compliance and central bank digital currencies. Their offerings include digital regulatory sandboxes for collaborative workflows, digital cash solutions, and tools for cross-border currency integration. By developing scalable and resilient digital infrastructure, EMTECH aims to support central banks in improving their operations and adapting to the demands of the Web3 era.
Earnipay
Seed Round in 2022
Earnipay is a business payment software that allows employers to provide their employees with instant access to earned salaries at any time, without altering existing payment processes. The platform integrates with employers' payroll systems, enabling employees to withdraw a portion of their daily earnings as needed. In addition to facilitating salary disbursement, Earnipay also offers financial education and personal finance management resources to promote the overall financial well-being of employees. Through these services, Earnipay aims to enhance the financial health of the workforce, benefiting both employers and their staff.
Instrumental
Series C in 2022
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to autonomously operate, learn, and adapt. This innovative approach significantly reduces scrap and rework costs for manufacturers, allowing them to address issues promptly and maintain higher production yields. The company's solutions are implemented in various global assembly lines, particularly among leading manufacturers. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, Instrumental aims to revolutionize the manufacturing industry by transforming inefficiencies into opportunities. In addition to its software offerings, Instrumental provides a range of services including performance analysis, architecture and design, and management consulting, catering to both commercial clients and government agencies. Based in Saint Paul, Minnesota, Instrumental has been active since 1991, focusing on creating impactful technological advancements in data-intensive environments.
Gemist
Seed Round in 2022
Gemist, Inc. is a jewelry company based in Los Angeles, California, specializing in customizable rings and accessories. Founded in 2018 and formerly known as Madeline's Rings Co., Gemist offers an innovative online platform where consumers can design their own jewelry pieces. The company provides a unique home "Try-and-Buy" experience, allowing customers to receive replicas of their customized designs before making a purchase. This approach is tailored to engage millennials in a personalized buying experience, and it incorporates technology for jewelry customization and virtual try-on. Gemist's platform not only enhances e-commerce but also aims to increase customer engagement and sales for jewelry brands.
Mantra Health
Series A in 2022
Mantra Health is a digital mental healthcare company focused on providing mental health services specifically for university students. The company has developed a platform that includes a proprietary Collaboration Portal, allowing universities to create tailored telemental health programs that enhance clinical outcomes and decrease the time students wait to access care. Mantra Health's platform offers a range of services, including psychiatric care, online assessments, initial video consultations, and personalized care plans, all designed to facilitate easy and comfortable treatment for students in their own homes. This approach aims to improve the overall mental health of students across various educational institutions.
Azibo
Series A in 2022
Azibo is a financial services platform for rental properties that provides solutions for rent collection, banking, lending, and insurance. The company was founded in 2018 and is headquartered in Reno, Nevada.
Treehouse
Seed Round in 2022
Treehouse is a venture-backed software-enabled home electrification startup focused on delivering turnkey EV charging solutions to EV buyers at the point of sale.
Apex.AI
Series B in 2021
Apex.AI, Inc. is a software company that focuses on developing solutions for autonomous mobility systems, particularly self-driving vehicles. Founded in 2017 and based in Palo Alto, California, the company offers Apex.OS, a software framework that simplifies the complexity of hardware and software integration through user-friendly APIs. Additionally, Apex.AI provides Apex.Autonomy, which is tailored for safety-critical applications, and MARV.Automotive, a versatile data management platform that facilitates data transfer between vehicles and the cloud. This platform allows for advanced analytics, data introspection, and team collaboration. Apex.AI's software products leverage open-source technologies, enabling developers to create secure and efficient applications for autonomous vehicles.
Edge Impulse
Series B in 2021
Edge Impulse is a software platform that facilitates the development of machine learning models optimized for edge devices, where data is collected either with or without connectivity. The platform streamlines the entire process of building, deploying, and scaling embedded machine learning applications, enabling developers to create intelligent devices. It supports the collection of real sensor data and incorporates live signal processing, allowing for the transformation of raw data into neural networks. Additionally, Edge Impulse offers capabilities for model testing and deployment to a variety of target devices, from microcontrollers to CPUs and GPUs, making it easier and faster for developers to manage machine learning applications for the edge.
Ottopay
Seed Round in 2021
Otto is an intelligent and automated debt management platform. We help the 8 in 10 Americans with debt save on interest, improve their credit score, and get debt-free faster — all done (you guessed it) automatically.
Sounding Board
Series B in 2021
Sounding Board is a coaching management platform that assists enterprises in enhancing their leadership capabilities through a combination of one-on-one coaching and advanced technology. Founded in 2016 and headquartered in Foster City, California, the company provides a comprehensive software solution that enables organizations to implement coaching initiatives on a large scale. Its platform features personalized development plans tailored to individual learning styles, along with automation tools that simplify administration. Additionally, Sounding Board offers a high-quality network of coaches available for on-demand needs, and robust data visualization tools to assess the overall impact of coaching across the organization. Serving clients in 11 countries, the company has achieved a notable Net Promoter Score, reflecting its commitment to fostering productive leadership and managerial behaviors that drive positive business outcomes.
Reibus
Series B in 2021
Reibus operates an online marketplace that facilitates the buying and selling of metals, serving businesses in industrial markets. The platform connects buyers with a wide network of metal suppliers and provides logistics support to ensure efficient transportation of materials. Reibus emphasizes features such as anonymous buying and real-time leads for sellers, promoting a transparent and streamlined transaction process. By offering a proprietary search tool and a simplified materials listing process, the company aims to maximize price performance, reduce time to market, and lower sales and marketing expenses for its users.
Jina AI
Series A in 2021
Jina AI is a Beijing-based company founded in 2020 that specializes in developing cloud-native neural search solutions powered by artificial intelligence and deep learning. The company offers a Search Foundation that includes Embeddings, Rerankers, and Small Language Models, allowing businesses and developers to leverage multimodal data effectively. Jina AI's open-source framework enables users to manage various types of data, facilitating the deployment, scaling, and orchestration of advanced search applications. By focusing on neural search technology, Jina AI aims to empower enterprises to create innovative generative AI and multimodal search solutions.
nTopology
Series D in 2021
nTopology, Inc. is an engineering software company that develops tools for manufacturing, focusing on design, simulation, and advanced manufacturing processes. Its flagship product, nTopology, allows engineers to create lightweight and optimized parts tailored to their functional requirements. The platform includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, which help eliminate geometry bottlenecks and enhance collaboration among teams. nTopology serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and headquartered in New York, the company aims to streamline workflows and integrate synthesized geometry with simulation data to produce manufacturing-ready models.
Clutch
Series B in 2021
Clutch is a technology company focused on transforming the car buying process by offering a fully online platform for purchasing high-quality certified vehicles. Customers can browse a diverse inventory of second-hand cars at competitive prices on Clutch's website, where they can complete their purchases without the need for showrooms or commissioned salespeople. The platform simplifies the car buying experience by providing easier financing options and delivering vehicles directly to customers' homes. Clutch aims to enhance customer satisfaction by delivering an enjoyable and convenient car buying experience while also making a positive impact in the communities it serves.
Papa
Series D in 2021
Papa, Inc. operates an online platform designed to connect college and nursing students with senior citizens in need of assistance and companionship. Founded in 2016 and headquartered in Miami, Florida, the platform facilitates a range of services including transportation for medical appointments, grocery shopping, house chores, technology assistance, and caregiving. By enabling older adults to access support from vetted companions, Papa helps them maintain their independence and enhances their quality of life while living at home. The platform not only addresses the practical needs of seniors but also fosters social connections, ensuring they receive both functional assistance and companionship.
Antiva Biosciences
Series D in 2021
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.
Dragos
Series D in 2021
Dragos is an industrial cybersecurity company focused on protecting critical infrastructure to safeguard civilization. It develops software that offers essential visibility into industrial control systems (ICS) and operational technology (OT) networks, allowing for the early identification and resolution of potential threats. The software is designed to support emerging applications such as the Industrial Internet of Things (IIoT), catering to clients in sectors including power and water utilities, energy, and manufacturing. By enhancing security measures, Dragos enables these industries to establish a resilient and adaptable security posture against evolving cyber threats.
Countable
Series A in 2021
Countable provides virtual community management for corporations, non-profits, and political campaigns. They use technology to communicate and human interconnectedness. They produce technology solutions that facilitate community engagement.
Appsmith
Series A in 2021
Appsmith is a developer of an open-source low-code application platform established in mid-2019. The platform enables developers to efficiently build, deploy, and manage custom internal applications, particularly focusing on CRUD functionalities. With over 5 million downloads and usage among more than 1,000 enterprises across over 100 countries, Appsmith aims to simplify the development of internal tools by streamlining operations, automating processes, and facilitating the integration of various applications and data. Additionally, the platform enhances legacy applications by allowing developers to incorporate new features, all while maintaining enterprise-grade security and governance.
TAG
Seed Round in 2021
TAG is a mobile application that allows users to access an e-money account through a debit card. They provide a money transfer feature that helps to transfer money to any bank or wallet. They specialize in digital wallets and payment services.
Bzaar
Seed Round in 2021
Bzaar is an online B2B cross-border marketplace that facilitates the purchase of a wide range of products, including home improvements, fashion, cookware, and bakeware, specifically for small businesses. Founded in 2020 and headquartered in San Francisco, California, Bzaar connects retailers with niche, artisanal products from value-based brands primarily located in South and South-East Asia. The platform offers small and medium-sized businesses a transparent and predictable buying experience, enabling them to access unique items that are typically unavailable through conventional big-box retail chains.
TrueFort
Series B in 2021
TrueFort Inc. is a cybersecurity company based in Weehawken, New Jersey, founded in 2015. It specializes in real-time application and cloud workload protection solutions, focusing on securing critical applications and infrastructure. The company's flagship platform, Fortress, offers a unique approach to security by leveraging advanced behavioral analysis, machine intelligence, and automation. This platform supports zero trust application environments and addresses various security challenges through a unified solution that enhances visibility and protection against cyber threats. TrueFort's technology enables clients to utilize agents already deployed in their systems, facilitating seamless integration while significantly reducing risks associated with excessive trust.
Tropic
Series A in 2021
Tropic provides a buyer enablement platform designed to assist finance and procurement teams in managing technology spending effectively. By integrating unbiased market data with spend management tools, Tropic enables organizations to reduce costs, enhance efficiency, and maintain visibility over their expenditures. The platform facilitates connections between businesses and vendors based on specific needs, streamlining the process of finding, researching, and managing vendor relationships. This approach not only saves time for buyers but also allows vendors to adjust their offerings or pricing, improving the likelihood of successful transactions. Overall, Tropic aims to optimize the buyer-seller dynamic by ensuring that product quality remains a central factor in achieving success.
Canopy
Series A in 2021
Canopy’s modern loan management and servicing platform helps Fintechs and brands service customer accounts through automations and APIs to help improve borrower repayment rates, increase net promoter scores, and decrease the cost of servicing for lending and credit card products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.